Abrdn Healthcare Opportunities (THQ)

$21.45

-0.08

(-0.37%)

Market is closed - opens 7 PM, 09 Sep 2024

Performance

  • $21.37
    $21.72
    $21.45
    downward going graph

    0.37%

    Downside

    Day's Volatility :1.61%

    Upside

    1.24%

    downward going graph
  • $15.29
    $22.10
    $21.45
    downward going graph

    28.72%

    Downside

    52 Weeks Volatility :30.81%

    Upside

    2.94%

    downward going graph

Returns

PeriodAbrdn Healthcare OpportunitiesRussel 2000Index (Russel 2000)
3 Months
6.19%
0.0%
0.0%
6 Months
6.4%
0.0%
0.0%
1 Year
17.47%
0.0%
0.0%
3 Years
-13.3%
-22.3%
-22.3%

Highlights

Analyst Recommendation

Technicals Summary

Sell

Neutral

Buy

Abrdn Healthcare Opportunities is currently in a neutral trading position according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Abrdn Healthcare Opportunities
Abrdn Healthcare Opportunities
4.28%
6.4%
17.47%
-13.3%
-8.45%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Abrdn Healthcare Opportunities
Abrdn Healthcare Opportunities
NA
NA
NA
NA
NA
NA
NA
NA
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Abrdn Healthcare Opportunities
Abrdn Healthcare Opportunities
NA
$903.2M
-8.45%
NA
NA

Company Information

tekla life sciences investors is a closed-ended equity mutual fund launched and managed by tekla capital management llc. the fund invests in public equity markets across the globe. it seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. the fund primarily invests in growth stocks of small cap companies. it employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. the fund benchmarks the performance of its portfolio against the nasdaq biotech index and the s&p 500 index. it was form

Organization
Abrdn Healthcare Opportunities
Employees
4
CEO
Industry
Miscellaneous

FAQs